Corticosteroids Added to Initial Intravenous Immunoglobulin Treatment for the Prevention of Coronary Artery Abnormalities in High‐Risk Patients With Kawasaki Disease

BACKGROUND: Randomized controlled trials previously provided different conclusions about the superiority of adding corticosteroids to initial intravenous immunoglobulin treatment for the prevention of coronary artery abnormalities in patients with Kawasaki disease (KD). To further assess this issue,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ae, Ryusuke, Abrams, Joseph Y., Maddox, Ryan A., Schonberger, Lawrence B., Nakamura, Yosikazu, Kuwabara, Masanari, Makino, Nobuko, Matsubara, Yuri, Kosami, Koki, Sasahara, Teppei, Belay, Ermias D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660775/
https://www.ncbi.nlm.nih.gov/pubmed/32811256
http://dx.doi.org/10.1161/JAHA.119.015308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660775/
https://www.ncbi.nlm.nih.gov/pubmed/32811256
http://dx.doi.org/10.1161/JAHA.119.015308

Ejemplares similares